Prostatic Neoplasms, Premature Menopause, Menorrhagia, Osteoporosis, Acne Vulgaris, Endometriosis, Pregnancy, Breast Neoplasms, Hypogonadism, Hot Flashes, Endometrial Hyperplasia, Primary Ovarian Insufficiency
Estradiol and norethindrone are used to treat symptoms of menopause, which is the time when a woman's menstrual periods stop permanently, such as hot flashes, which are sudden feelings of warmth, and vaginal dryness, which is a lack of moisture in the vaginal area. They also help prevent osteoporosis, which is a condition where bones become weak and brittle, in postmenopausal women.
Estradiol, which is a form of estrogen, replaces the estrogen that the body no longer produces, helping to relieve menopausal symptoms. Norethindrone, which is a type of progestin, regulates the menstrual cycle and prevents the thickening of the uterine lining, which is the inner layer of the uterus. Together, they balance hormone levels in the body, improving overall quality of life during menopause.
Estradiol is typically taken in doses ranging from 0.5 mg to 2 mg per day, while norethindrone is usually given in doses of 0.1 mg to 1 mg per day. These medications are taken orally, which means by mouth, and should be taken at the same time each day to maintain consistent hormone levels. The exact dosage is determined by a healthcare provider based on individual needs.
Common side effects of estradiol and norethindrone include nausea, which is a feeling of sickness with an inclination to vomit, headache, breast tenderness, and mood changes. Estradiol may cause bloating, which is a feeling of fullness in the abdomen, and weight changes. Norethindrone can lead to changes in menstrual flow and spotting, which is light bleeding between periods.
Estradiol and norethindrone increase the risk of blood clots, which are clumps of blood that can block blood vessels, stroke, which is a condition where blood flow to the brain is interrupted, and certain cancers like breast cancer. They should not be used during pregnancy or breastfeeding. Smokers and women over 35 have higher risks. Regular monitoring by a healthcare provider is essential to manage these risks.
US(FDA)
NO
NO
Estrogen, Progestin
NO